Breast cancer and exercise: The role of adiposity and immune markers

Maturitas

Volumn 105, Issue , 2017, Pages 16-22

  Pudkasam, Supa ^a,b   Tangalakis, Kathy ^a   Chinlumprasert, Nanthapan ^b   Apostolopoulos, Vasso ^a   Stojanovska, Lily ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b ASSUMPTION UNIVERSITY   (Thailand)

Author keywords

Adiposity; Biomarkers; Breast cancer; Breast cancer outcome; Exercise; Immune biomarkers

Indexed keywords

BIOLOGICAL MARKER;

AEROBIC EXERCISE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; EPIDEMIOLOGICAL DATA; ETHNIC OR RACIAL ASPECTS; EXERCISE; HUMAN; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; LIPID METABOLISM; MORTALITY RATE; OBESITY; OUTCOME ASSESSMENT; REVIEW; RISK FACTOR; TREND STUDY; ANIMAL; BREAST TUMOR; FEMALE; IMMUNOLOGY;

ADIPOSITY; ANIMALS; BIOMARKERS; BREAST NEOPLASMS; EXERCISE; FEMALE; HUMANS;

EID: 85019247079     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2017.04.022     Document Type: Review

References (64)

1. Travier, N., Velthuis, M.J., Steins Bisschop, C.N., van den Buijs, B., Monninkhof, E.M., Backx, F., et al. Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial. BMC Med., 2015, 121, 10.1186/s12916-015-0362-z.
2. Youlden, D.R., Cramb, S.M., Dunn, N.A., Muller, J.M., Pyke, C.M., Baade, P.D., The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 36:3 (2012), 237–248, 10.1016/j.canep.2012.02.007.
3. World Health Organization, Global strategy on diet, physical activity and health. 2004 http://apps.who.int/iris/bitstream/10665/43035/1/9241592222_eng.pdf?ua=1.
4. Guinan, E.M., Connolly, E.M., Hussey, J., Exercise training in breast cancer survivors: a review of trials examining anthropometric and obesity-related biomarkers of breast cancer risk. Phys. Therapy Rev., 18(11), 2013, 10.1179/1743288X12Y.0000000057.
5. Neilson, H.K., Friedenreich, C.M., Brockton, N.T., Millikan, R.C., Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol. Biomark. Prevent. 18:1 (2009), 11–27, 10.1158/1055-9965.epi-08-0756.
6. Schmidt, S., Monk, J.M., Robinson, L.E., Mourtzakis, M., The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. Obesity Rev. 16:6 (2015), 473–487, 10.1111/obr.12281.
7. Hutnick, N.A., Williams, N.I., Kraemer, W.J., Orsega-Smith, E., Dixon, R.H., Bleznak, A.D., Mastro, A.M., Exercise and lymphocyte activation following chemotherapy for breast cancer. Med. Sci. Sports Exercise 37:11 (2005), 1827–1835, 10.1249/01.mss.0000175857.84936.1a.
8. Fairey, A.S., Courneya, K.S., Field, C.J., Bell, G.J., Jones, L.W., Mackey, J.R., Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J. Appl. Physiol. 98:4 (2005), 1534–1540, 10.1152/japplphysiol.00566.2004.
9. The International Agency for Research on Cancer, Breast cancer estimated incidence, mortality and prevalence worldwide in 2012. 2012 http://globocan.iarc.fr/old/FactSheets/cancers/breast-new.asp.
10. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA: Cancer J. Clinicians 65:2 (2015), 87–108, 10.3322/caac.21262.
11. DeSantis, C.E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B.O., Jemal, A., International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol. Biomarkers Prev. 24:10 (2015), 1495–1506, 10.1158/1055-9965.epi-15-0535.
12. DeSantis, C.E., Fedewa, S.A., Goding Sauer, A., Kramer, J.L., Smith, R.A., Jemal, A., Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA: A Cancer J. Clinicians 66:1 (2016), 31–42, 10.3322/caac.21320.
13. Toriola, A.T., Colditz, G.A., Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res. Treatment 138:3 (2013), 665–673, 10.1007/s10549-013-2500-7.
14. Coombs, N.J., Cronin, K.A., Taylor, R.J., Freedman, A.N., Boyages, J., The impact of changes in hormone therapy on breast cancer incidence in the US population. Cancer Causes Control 21:1 (2010), 83–90, 10.1007/s10552-009-9437-5.
15. Mahon, S.M., Site-specific cancer series: Breast cancer. 2nd ed., 2011, Oncology Nursing Society, Pittsburgh, PA.
16. Colditz, G.A., Bohlke, K., Berkey, C.S., Breast cancer risk accumulation starts early: prevention must also. Breast Cancer Res. Treatment 145:3 (2014), 567–579, 10.1007/s10549-014-2993-8.
17. Colditz, G.A., Rosner, B., Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am. J. Epidemiol. 152:10 (2000), 950–964.
18. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288:3 (2002), 321–333.
19. Vessey, M.P., Effect of endogenous and exogenous hormones on breast cancer: epidemiology. Verhandlungen der Deutschen Gesellschaft für Pathologie Deutsche Gesellschaft für Pathologie 81 (1997), 493–501.
20. Stuebe, A.M., Willett, W.C., Xue, F., Michels, K.B., Lactation and incidence of premenopausal breast cancer: a longitudinal study. Archiv. Internal Med. 169:15 (2009), 1364–1371, 10.1001/archinternmed.2009.231.
21. Chen, S., Parmigiani, G., Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol. 25:11 (2007), 1329–1333, 10.1200/jco.2006.09.1066.
22. Apostolopoulos, V., de Courten, M., Stojanovska, L., Obesity: An Immunological Perspective. J. Immune Res., 1(3), 2014.
23. Divella, R., De Luca, R., Abbate, I., Naglieri, E., Daniele, A., Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J. Cancer 7:15 (2016), 2346–2359, 10.7150/jca.16884.
24. Eliassen, A.H., Colditz, G.A., Rosner, B., Willett, W.C., Hankinson, S.E., Adult weight change and risk of postmenopausal breast cancer. J. Am. Med. Assoc. 296:2 (2006), 193–201, 10.1001/jama.296.2.193.
25. Hede, K., Fat may fuel breast cancer growth. J. Natl. Cancer Inst. 100:5 (2008), 298–299, 10.1093/jnci/djn050.
26. Lorincz, A.M., Sukumar, S., Molecular links between obesity and breast cancer. Endocrine Related Cancer. 13:2 (2006), 279–292, 10.1677/erc.1.00729.
27. Munoz-de-Toro, M., Durando, M., Beldomenico, P.M., Beldomenico, H.R., Kass, L., Garcia, S.R., Luque, E.H., Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas. Breast Cancer Res., 8(4), 2006, R47, 10.1186/bcr1534.
28. Apostolopoulos, V., de Courten, M., Stojanovska, L., Blatch, G.L., Tangalakis, K., de Courten, B., The complex immunological and inflammatory network of adipose tissue in obesity. Mol. Nutr. Food Res. 60:1 (2016), 43–57, 10.1002/mnfr.201500272.
29. Hippocrates quotes. https://thepowergardener.com/2012/07/22/the-best-hippocratesphysical-activity-quote/.
30. Kuper, S., The man who invented exercise. 2009 September 12, Financial Times https://www.ft.com/content/e6ff90ea-9da2-11de-9f4a-00144feabdc0.
31. Gleeson, M., Bishop, N.C., Stensel, D.J., Lindley, M.R., Mastana, S.S., Nimmo, M.A., The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 11:9 (2011), 607–615, 10.1038/nri3041.
32. Pinto, A., Di Raimondo, D., Tuttolomondo, A., Butta, C., Milio, G., Licata, G., Effects of physical exercise on inflammatory markers of atherosclerosis. Curr. Pharmaceut. Design 18:28 (2012), 4326–4349.
33. Coen, P.M., Flynn, M.G., Markofski, M.M., Pence, B.D., Hannemann, R.E., Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population. Metabolism 59:12 (2010), 1775–1783, 10.1016/j.metabol.2010.05.002.
34. World Health Organization, Physical Activity Fact Sheet. 2006 http://www.who.int/mediacentre/factsheets/fs385/en/.
35. Long, G., Watkinson, C., Brage, S., Morris, J., Tuxworth, B., Fentem, P., et al. Mortality benefits of population-wide adherence to national physical activity guidelines: a prospective cohort study. Eur. J. Epidemiol. 30:1 (2015), 71–79, 10.1007/s10654-014-9965-5.
36. Apostolopoulos, V., Borkoles, E., Polman, R., Stojanovska, L., Physical and immunological aspects of exercise in chronic diseases. Immunotherapy 6:10 (2014), 1145–1157, 10.2217/imt.14.76.
37. Zaldivar, F., Wang-Rodriguez, J., Nemet, D., Schwindt, C., Galassetti, P., Mills, P.J., et al. Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes. J. Appl. Physiol. (1985) 100:4 (2006), 1124–1133, 10.1152/japplphysiol.00562.2005.
38. Liu, D., Wang, R., Grant, A.R., Zhang, J., Gordon, P.M., Wei, Y., Chen, P., Immune adaptation to chronic intense exercise training: new microarray evidence. BMC Genomics, 18(1), 2017, 29, 10.1186/s12864-016-3388-5.
39. Kyu, H.H., Bachman, V.F., Alexander, L.T., Mumford, J.E., Afshin, A., Estep, K., et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. Br. Med. J., 354, 2016, i3857, 10.1136/bmj.i3857.
40. Colditz, G.A., Bohlke, K., Priorities for the primary prevention of breast cancer. CA: Cancer J. Clinicians 64:3 (2014), 186–194, 10.3322/caac.21225.
41. Lynch, B.M., Neilson, H.K., Friedenreich, C.M., Physical activity and breast cancer prevention. Recent Results Cancer Res. 186 (2011), 13–42, 10.1007/978-3-642-04231-7_2.
42. Boeke, C.E., Eliassen, A.H., Oh, H., Spiegelman, D., Willett, W.C., Tamimi, R.M., Adolescent physical activity in relation to breast cancer risk. Breast Cancer Res. Treatment 145:3 (2014), 715–724, 10.1007/s10549-014-2919-5.
43. Tworoger, S.S., Rosner, B.A., Willett, W.C., Hankinson, S.E., The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res., 13(5), 2011, R99, 10.1186/bcr3040.
44. Irwin, M.L., McTiernan, A., Manson, J.E., Thomson, C.A., Sternfeld, B., Stefanick, M.L., et al. Physical activity and survival in postmenopausal women with breast cancer: results from the women's health initiative. Cancer Prevent. Res. (Philadelphia, PA) 4:4 (2011), 522–529, 10.1158/1940-6207.capr-10-0295.
45. Naraphong, W., Lane, A., Schafer, J., Whitmer, K., Wilson, B.R., Exercise intervention for fatigue-related symptoms in Thai women with breast cancer: A pilot study. Nurs. Health Sci., 2014, 10.1111/nhs.12124.
46. Pastakia, K., Kumar, S., Exercise parameters in the management of breast cancer: a systematic review of randomized controlled trials. Physiotherapy Res. Int. 16:4 (2011), 237–244, 10.1002/pri.505.
47. Ballard-Barbash, R., Friedenreich, C.M., Courneya, K.S., Siddiqi, S.M., McTiernan, A., Alfan, C.M., Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J. Natl. Cancer Inst. 104:11 (2012), 815–840, 10.1093/jnci/djs207.
48. Campbell, K.L., Van Patten, C.L., Neil, S.E., Kirkham, A.A., Gotay, C.C., Gelmon, K.A., McKenzie, D.C., Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. J. Acad. Nutr. Diet. 112:4 (2012), 559–567, 10.1016/j.jada.2011.10.022.
49. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:12 (2003), 1821–1830, 10.1172/jci19451.
50. McTiernan, A., Tworoger, S.S., Ulrich, C.M., Yasui, Y., Irwin, M.L., Rajan, K.B., et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 64:8 (2004), 2923–2928.
51. Kaaks, R., Rinaldi, S., Key, T.J., Berrino, F., Peeters, P.H., Biessy, C., et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr. Relat. Cancer 12:4 (2005), 1071–1082, 10.1677/erc.1.01038.
52. Borugian, M.J., Sheps, S.B., Kim-Sing, C., Van Patten, C., Potter, J.D., Dunn, B., et al. Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?. Cancer Epidemiol. Biomarkers Prev. 13:7 (2004), 1163–1172.
53. Scott, E., Daley, A.J., Doll, H., Woodroofe, N., Coleman, R.E., Mutrie, N., et al. Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial. Cancer Causes Control. 24:1 (2013), 181–191, 10.1007/s10552-012-0104-x.
54. Harrigan, M., Cartmel, B., Loftfield, E., Sanft, T., Chagpar, A.B., Zhou, Y., et al. Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. J. Clin. Oncol. 34:7 (2016), 669–676, 10.1200/JCO.2015.61.6375.
55. Hursting, S.D., Obesity, energy balance, and cancer: a mechanistic perspective. Cancer Treatment Res. 159 (2014), 21–33, 10.1007/978-3-642-38007-5_2.
56. Schmitz, K.H., Ahmed, R.L., Hannan, P.J., Yee, D., Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol. Biomarkers Prev. 14:7 (2005), 1672–1680, 10.1158/1055-9965.epi-04-0736.
57. Eccles, S.A., Aboagye, E.O., Ali, S., Anderson, A.S., Armes, J., Berditchevski, F., et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res., 15(5), 2013, R92, 10.1186/bcr3493.
58. Goh, J., Niksirat, N., Campbell, K.L., Exercise training and immune crosstalk in breast cancer microenvironment: exploring the paradigms of exercise-induced immune modulation and exercise-induced myokines. Am. J. Translational Res. 6:5 (2014), 422–438.
59. Hakim, F.T., Cepeda, R., Kaimei, S., Mackall, C.L., McAtee, N., Zujewski, J., et al. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:9 (1997), 3789–3798.
60. Gonzalez, F.M., Vargas, J.A., Lopez-Cortijo, C., Castejon, R., Gorriz, C., Ramirez-Camacho, R., et al. Prognostic significance of natural killer cell activity in patients with laryngeal carcinoma. Archiv. Otolaryngol. Head Neck Surg. 124:8 (1998), 852–856.
61. Veljkovic, M., Dopsaj, V., Dopsaj, M., Branch, D.R., Veljkovic, N., Sakarellos-Daitsiotis, M.M., et al. Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy. PLoS ONE, 6(11), 2011, e28304, 10.1371/journal.pone.0028304.
62. Ergun, M., Eyigor, S., Karaca, B., Kisim, A., Uslu, R., Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients. Eur. J. Cancer Care (Engl) 22:5 (2013), 626–637, 10.1111/ecc.12068.
63. Zimmer, P., Baumann, F.T., Bloch, W., Zopf, E.M., Schulz, S., Latsch, J., et al. Impact of a half marathon on cellular immune system, pro-inflammatory cytokine levels, and recovery behavior of breast cancer patients in the aftercare compared to healthy controls. Eur. J. Haematol. 96:2 (2016), 152–159, 10.1111/ejh.12561.
64. Hagstrom, A.D., Marshall, P.M., Lonsdale, C., Papalia, S., Cheema, B.S., Toben, C., et al. The effect of resistance training on markers of immune function and inflammation in previously sedentary women recovering from breast cancer: a randomized controlled trial. Breast Cancer Res. Treatment 155:3 (2016), 471–482, 10.1007/s10549-016-3688-0.